Laurion Capital Management »

Aktis Oncology shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 100k 17.89

More positions owned by Laurion Capital Management

Electronic Arts (EA)
Norfolk Southern (NSC)
Bridgebio Pharma (BBIO)
Warner Bros Discovery Com Ser A (WBD)
JPMorgan Chase & Co. (JPM)
Mineralys Therapeutics (MLYS)
NVIDIA Corporation (NVDA)
Caterpillar (CAT)
Hologic
Oracle Corporation (ORCL)
Ge Vernova (GEV)
Broadcom (AVGO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Laurion Capital Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology